TG THERAPEUTICS, INC.
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Dec 31, 2024
10-K filed 2026-03-12
Suppliers 1
Companies that disclose TGTX as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from TGTX | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| DTIL PRECISION BIOSCIENCES INC |
12% | $8.2M | FY 2024-12-31 | Lapsed Last seen 2024-12-31 |
10-K 2026-03-12 | |
Revenue from Prevail Therapeutics, Inc. (“Prevail”) and TG Therapeutics (as defined below) accounted for 77% and 12% of revenue during the year ended December 31, 2024, respectively. | ||||||
Alerts are coming
Get an email when TGTX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.